In an in vitro study, EMC10 was suggested as a potential therapeutic target for malignant glioblastoma after being found to exert cell proliferation inhibition, invasion, angiogenesis in endothelial cells, and cell migration in glioma cell lines.19, 20. This evidence concerns the gene EMC10 and central nervous system cancer.